Cencora, Inc.
Cencora is a global pharmaceutical sourcing and distribution company with a significant political signal from concentrated congressional selling, where one member executed 6 sales totaling up to $675K in the last 12 months.
BusinessWhat COR does
Cencora operates as a pharmaceutical wholesale and distribution company, connecting manufacturers with healthcare providers. Its revenue is derived from drug distribution, specialty pharmacy, and consulting services. The company's model is heavily exposed to pharmaceutical supply chain regulation and reimbursement policies.
12 months past · 3 months futureCOR activity timeline
Executive Branch ConflictsCOR held by Trump-administration officials
Lifetime Government AwardsCOR federal contracts
COR doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Politicians Trading CORMembers of Congress with recent COR positions
Congressional TradesWho in Congress is trading COR
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting CORLive legislation impacting this stock
Political ProfileWhere COR sits in Washington
[object Object]
STRUCTURAL: High regulatory density (score: 85) from 8 active healthcare bills. EVIDENTIARY: Concentrated, high-value selling by a single congressman (Rep. McCaul, up to $675K across 6 sales) and a separate sale by Rep. Slotkin; only one small buy offsets. Net: Evidentiary selling pressure dominates a neutral structural backdrop.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened legislative scrutiny on pharmaceutical supply chains and pricing.U.S. Congress"8 recent healthcare bills with non-zero estimated revenue impact from `Recent bill_impacts`."
Regulatory opportunities
- No specific regulatory opportunities flagged.
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
Live signals + predictions for COR — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades COR
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord